MBL949 Arm 4 for Obesity

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
ObesityMBL949 - Drug
Eligibility
18 - 60
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new drug to see if it's safe and effective for weight loss in obese people with or without diabetes.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Baseline to Day 169

Baseline to Day 169
Frequency and severity of Adverse Events
Week 16
Change-from-baseline in weight

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

6 Treatment Groups

MBL949 Arm 4
1 of 6
MBL949 Arm 1
1 of 6
MBL949 Arm 5
1 of 6
MBL949 Arm 2
1 of 6
MBL949 Arm 3
1 of 6
Placebo
1 of 6

Active Control

Non-Treatment Group

127 Total Participants · 6 Treatment Groups

Primary Treatment: MBL949 Arm 4 · Has Placebo Group · Phase 2

MBL949 Arm 4
Drug
ActiveComparator Group · 1 Intervention: MBL949 · Intervention Types: Drug
MBL949 Arm 1
Drug
ActiveComparator Group · 1 Intervention: MBL949 · Intervention Types: Drug
MBL949 Arm 5
Drug
ActiveComparator Group · 1 Intervention: MBL949 · Intervention Types: Drug
MBL949 Arm 2
Drug
ActiveComparator Group · 1 Intervention: MBL949 · Intervention Types: Drug
Placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug
MBL949 Arm 3
Drug
ActiveComparator Group · 1 Intervention: MBL949 · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to day 169

Who is running the clinical trial?

Novartis PharmaceuticalsLead Sponsor
2,735 Previous Clinical Trials
3,543,916 Total Patients Enrolled
6 Trials studying Obesity
793 Patients Enrolled for Obesity

Eligibility Criteria

Age 18 - 60 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Tennessee50.0%
Texas40.0%
Ohio10.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Novartis Investigative Site100.0%
What portion of applicants met pre-screening criteria?
Met criteria77.8%
Did not meet criteria22.2%
How many prior treatments have patients received?
050.0%
125.0%
225.0%
What questions have other patients asked about this trial?
  • "How long does this trial last?"
Why did patients apply to this trial?
  • "I am eager to participate in a clinical trial that may benefit me and so many others who need to find solutions for weight loss."

How responsive is this trial?

Average response time
  • < 2 Days
Typically responds via
Email100.0%
Most responsive sites:
  1. Novartis Investigative Site: < 48 hours

Frequently Asked Questions

What are the eligibility criteria for participating in this clinical experiment?

"To take part in this research, patients must be between 18 and 60 years of age and have a diagnosis of obesity. We are hoping to enrol 106 individuals for the duration of the trial." - Anonymous Online Contributor

Unverified Answer

Are recruitment efforts ongoing for this research trial?

"As per clinicaltrials.gov, this medical trial is still open for recruitment of patients. It first appeared on February 10th 2022 and was recently modified on April 5th 2022." - Anonymous Online Contributor

Unverified Answer

Is the age eligibility for this trial restricted to those over 45 years of age?

"Precisely speaking, the enrollment criteria for this medical trial necessitates that applicants are between 18 and 60 years old. Moreover, there are 203 studies available to those under 18 while 595 trials cater to individuals over 65." - Anonymous Online Contributor

Unverified Answer

How many locales are hosting this experiment?

"At present, 4 different medical centres have opened their doors to participants of this trial. These locations are based in Miami Beach, Dallas and Morehead City among others; thus it is advised that those wishing to take part select the clinic closest to them so as to abate travel costs." - Anonymous Online Contributor

Unverified Answer

Has the MBL949 Arm 4 been given a regulatory green light by the FDA?

"Although there is limited evidence to suggest the efficacy of MBL949 Arm 4, its safety has been determined by our team at Power as a 2 due to Phase 2 trials." - Anonymous Online Contributor

Unverified Answer

What is the total number of individuals participating in this experiment?

"Affirmative. Per the information present on clinicaltrials.gov, this medical trial is currently accepting applications. This study was first made public on February 10th 2022 and has been updated as recently as April 5th 2022. 106 participants are sought from 4 distinct locations for the experiment to take place." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.